Secretary, Department of Health & Ageing v Pagasa Australia Pty Ltd

In the matter of Secretary, Department of Health & Ageing v Pagasa Australia Pty Ltd, the Federal Court was presented with a dispute regarding the importation and sale of certain therapeutic goods without proper registration or listing under the Therapeutic Goods Act 1989 (Cth). The Secretary, Department of Health & Ageing, acting on behalf of the Commonwealth, brought an action against Pagasa Australia Pty Ltd and related entities, alleging that they had contravened the Act by importing and distributing therapeutic goods that were not registered, listed, or exempt as required by the legislation. The Secretary sought declaratory relief, the imposition of pecuniary penalties, and the forfeiture of the imported goods.

The central legal issue before the court was whether Pagasa Australia Pty Ltd and its associated entities had indeed contravened the Act by importing and distributing therapeutic goods without the necessary registration, listing, or exemption. Specifically, the court had to determine if the goods listed in the Statement of Agreed Facts were imported in breach of section 19D(1)(a)(i) of the Act. Additionally, the court needed to decide on the appropriate penalties and relief to be imposed in light of the contraventions identified.

The Federal Court found that the Respondents had indeed contravened the Act by importing the specified therapeutic goods without the necessary registration, listing, or exemption. The court granted the declaratory relief as requested by the Secretary, detailing the specific goods involved and the nature of the contravention. The court also imposed a pecuniary penalty of $130,000 on the Respondents and ordered the forfeiture of the imported goods to the Commonwealth. Furthermore, the Respondents were ordered to pay the Secretary’s costs on an indemnity basis. The court's decision was based on the clear contravention of the Act as per the Statement of Agreed Facts, and the significant public interest in enforcing the regulatory framework governing therapeutic goods in Australia.

In conclusion, the court issued comprehensive orders to address the contraventions of the Therapeutic Goods Act 1989. The Respondents were required to pay the pecuniary penalty and costs within 42 days and the imported goods were to be forfeited to the Commonwealth. This decision underscores the importance of compliance with therapeutic goods regulations and the court's role in enforcing these laws to protect public health and safety.